Clinical Trial Update: ALL Backbone in AYAs [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the ALL Backbone regimen in adolescents and young adults with acute lymphoblastic leukemia; the study is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Leukemia
• Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia | Phase 2 | Status: NOT_YET_RECRUITING